About the Company

百极弘烨医药科技有限公司创立于2018年,是一家处于临床阶段、聚焦三大血液肿瘤创新药物研发的生物医药公司,致力于发现和开发血液肿瘤领域新型、差异化疗法,为血液肿瘤患者提供治疗新策略。
公司建立了血液肿瘤小分子药物研发平台,拥有持续自主创新研发能力。已战略性地设计并开发了十余个 BIC 和 FIC 小分子项目组成的丰富研发管线,其中两项已进入临床I期试验,多个具有全球竞争力的创新项目即将进入临床。
公司核心团队具有丰富的创新药研发经验,覆盖药物发现、临床前研究、临床转化、申报注册到临床开发的全研发链条。公司位于江苏南通和上海张江两大新药研发基地,目前研发及管理人员已超过 50 人。

Expand
Information is aggregated from the web and may not be exact. For reference only.
Information incorrect? Claim this company to edit

百极弘烨 honors, qualifications & industry associations

Tags are labelled based on keyword text matching analysis and may be related to the company. For reference only.

百极弘烨 Related Industry Tags

Business Registration

Provided by

Operating Status: 开业
Registered Capital: 776.1975万(元)
Legal Representative: 高安慧
Date Established:
Credit Code: 91320684MA1W4WR842
Registered Address: 中山市南朗街道翠亨新区香山大道37号A1幢7层709室

People who follow 百极弘烨 also follow

百极弘烨 Competitors (Similar Companies)

生物科技/生物工程 医药 生物医药 药用辅料
生物科技/生物工程 医药 生物医药 化妆品
营养食品制造 生产 食品 营养食品
“人类药品和医疗器械,现代化制药上市企业”
招标代理 政府采购代理 工程招标 招投标
塑料制品 生产 工业 律师事务所/法律服务

Report

*Reason:

Radical political or ideological topics
Advertising or spam
Pornographic or vulgar content
Obscene language or personal attacks
Other

Congratulations, submitted successfully!

Your edit is under review. You will be notified by email within 1 business day.

Submission failed.

Followed successfully. We'll notify you of any company updates.

Help others learn about this company, add my impression of this company»

Log in with the following accounts to save your follows

Followed successfully, we'll notify you of any company updates